About Noselab

Our Vision

Our goal is to drive a paradigm shift in diagnosis, understanding and treatment of brain diseases.

The foundation of Noselab is a new proprietary ground-breaking diagnostic platform to detect, assess and classify molecular biomarkers through the analysis of nasal secretion.

This unique diagnostic procedure is complemented with an innovative, data-driven medical approach, enabling comprehensive patient profiling, improving the understanding of the disease, as well as supporting personalized treatment decisions.

Who We Are

We are passionate about enabling patients to enjoy more unburdened years in their lives, supporting caregivers and families, while significantly improving global health economics.

Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee

Get to Know Our Team

Noselab was founded by Dr. Mareike Albert and Thomas Heydler in May 2020 in Munich, Germany. We are an interdisciplinary and experienced team with all necessary aspects to drive our vision forward.

Dr. Peter Fruhstorfer

Chief Executive Officer

Dr. Mareike Albert

Founder & Chief Scientific Officer

Thomas Heydler

Founder & Chief Strategy Officer

Dr. Markus Rinecker

Chief Financial Officer

PD Dr. med. Marion San Nicoló

Clinical & Business Development

Dr. Sabine Mertzig

Research & Development and Product Management

Arno Schäpe

Digital Strategy and Innovation

Dr. Gerald Möller

Chairman of the Supervisory Board

Dr. Peter Kaspar

Chairman of the Scientific Advisory Board

Our Network

We work with strong partners at our side. Discover our network.

Development & Business Partners

Clinical Partners

Grants

Our Progress So Far

Since its founding in May 2020, Noselab has gained strong traction in developing its novel platform, generating awareness, and preparing for commercialization.

Started commercialization

Enrolled more than 1300 patients

Showed solid clinical evidence

Established strong clinical network

Implemented data and analytics platform

Built comprehensive analytical workbench

Developed proprietary sampling solution

Established strong partner network

Won top-class advisory team

Experienced leadership team

Raised total of 14.0M €

Founded in May 2020

You want to participate and engage in something that makes a difference? Join us in uncovering the secret!